TXNDC5 and chronic kidney disease: Since TXNDC5 is a key player in the development of cardiac fibrosis and has been shown to be highly expressed in kidney fibroblasts, it is reasonable to assume that targeting TXNDC5 in the treatment of kidney fibrosis and chronic kidney disease (CKD) could have therapeutic benefits [11].